InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,703.37
(
-0.27%
)
US TECH 100
19,250.00
(
-0.37%
)
Dow Jones
42,154.06
(
0.07%
)
Brent Oil
74.29
(
0.75%
)
Bitcoin
62,799.48
(
-0.83%
)
Post# of 403524
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Rdunn88

Send PM Follow Ignore
Followers 26
Posts 8986
Boards Moderated 0
Alias Born 12/11/2013

Rdunn88

Re: None

Tuesday, 11/09/2021 3:20:01 PM

Tuesday, November 09, 2021 3:20:01 PM

Post# of 403524
B article on another site just out...

https://www.news-medical.net/news/20211109/COVID-19-drug-candidate-with-wide-ranging-antiviral-activity.aspx

Conclusion

The current research showed that Brilacidin is a potential antiviral agent with a dual antiviral mechanism of action, i.e., targeting host cell surface HSPGs to inhibit viral attachment and disrupting the integrity of viral particles, making them inactive. The dual action could slow down the development of viral resistance. Considering its mechanism of action and broad-spectrum antiviral activity against several coronaviruses, the authors recommend the development of Brilacidin based treatment that could be effective against the existing and future emerging coronaviruses.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent IPIX News
More IPIX News
InvestorsHub NewsWire

FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM

FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM

Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM

VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM

Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM

HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM

Start posting your company's news
Only $200 per official company press release!